Skip Navigation LinksHome > January 2012 - Volume 15 - Issue 1 > Chronic low-grade inflammation and age-related sarcopenia
Current Opinion in Clinical Nutrition & Metabolic Care:
doi: 10.1097/MCO.0b013e32834dd297
AGEING: BIOLOGY AND NUTRITION: Edited by Ronni Chernoff and Tommy Cederholm

Chronic low-grade inflammation and age-related sarcopenia

Beyer, Ingoa,b; Mets, Tonya,b,c; Bautmans, Ivana,b,c

Free Access
Article Outline
Collapse Box

Author Information

aGeriatrics Department, Universitair Ziekenhuis Brussel

bFrailty in Ageing Research Unit

cGerontology Department, Vrije Universiteit Brussel, Brussels, Belgium

Correspondence to Ivan Bautmans, Frailty in Ageing Research Department, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. Tel: +32 24776366; fax: +32 24776364; e-mail:

Collapse Box


Purpose of review: Age-related chronic low-grade inflammatory profile (CLIP) has been recognized as an important causative factor for sarcopenia. Here, we report the recent evidence concerning CLIP and sarcopenia.

Recent findings: Twenty-one studies were included (12 observational, five interventional studies and four randomized controlled trials). Observational studies strengthen the association between CLIP and sarcopenia in cross-sectional and longitudinal designs. Interleukin (IL)-6 and tumour necrosis factor-α are the most reported inflammatory parameters. Biopsy studies confirm the role of oxidative mechanisms, protein kinase B and nuclear factor kappa-light-chain-enhancer of activated B cells pathways and implicate stress response mechanisms and heat shock protein. Adipose tissue as source of inflammatory cytokines remains unclear and correction for fat mass is advisable in new research. Exercise interventions (both aerobic and resistance training) demonstrate beneficial effects on CLIP even in the absence of decreases in weight, BMI or fat mass. IL-6 is also released during exercise, in hormone-like fashion unrelated to inflammation, and exercise-induced IL-6 changes require careful interpretation. Soy supplementation in one study showed no influence on CLIP and no recent pharmacological trials were retrieved.

Summary: Associations between CLIP and sarcopenia are observed quite consistently and underlying mechanisms become apparent. Exercise remains the mainstay intervention to lower CLIP and counter sarcopenia. More research is warranted to unravel the exact dose–response relationship.

Back to Top | Article Outline


Ageing is accompanied by reduced muscle mass and strength, defined as sarcopenia [1]. Catabolic inflammatory processes will enhance this process, especially at advanced age [2]. Even healthy ageing results in slight elevations of circulating proinflammatory mediators, corresponding to a chronic low-grade inflammatory profile (CLIP) [3]. Elderly persons presenting pronounced CLIP show lower muscle mass and muscle strength [4]. Causes of ageing-related CLIP include alterations in T-cell function, immune cell senescence, alteration of the extracellular matrix, increased fat mass and foci of chronic infection [5].

Elderly people possess an important residual, but latent, physical potential, which can be mobilized by training. Physical exercise has also strong regulating and favourable effects on CLIP [6], for example, by lowering expression of TLR4 leading to lower lipopolysaccharide (LPS)-induced cytokine release [7]. Physical exercise would thus reduce both the basal inflammatory status and the acute inflammatory response upon aggression in the aged. CLIP is part of the concept of ‘inflammaging’ [8] that describes a benefit at young age from a highly responsive immune system showing good resistance against infections, but a disadvantage when ageing by higher CLIP and sarcopenia. ‘Anti-inflammaging’ refers to low inflammatory responses rendering more susceptible to infectious diseases at young age, but resulting in lower CLIP and survival advantage in old age [8]. In this context, physical exercise would shift patients from an ‘inflammaging’ towards an ‘anti-inflammaging’ profile.

The aim of this review is to report the recent evidence concerning the links between CLIP and sarcopenia.

Box 1
Box 1
Image Tools
Back to Top | Article Outline


PubMed [search key: (‘Sarcopenia’ [Mesh] OR ‘Muscle, Skeletal’ [Mesh] OR ‘Muscular Atrophy’ [Mesh] OR ‘Muscle Weakness’ [Mesh] OR dynapenia) AND (‘Inflammation’ [Mesh] OR ‘Chemokines’ [Mesh] OR ‘Cytokines’ [Mesh] OR ‘Receptors, Cytokine’ [Mesh] OR ‘Acute-Phase Proteins’ [Mesh] OR ‘Acute-Phase Reaction’ [Mesh])] and Web-of-Science (search key: TS = (sarcopenia OR skeletal muscle OR muscle atrophy OR muscle weakness OR dynapenia) AND TS = (inflammation OR cytokine* OR acute phase*) AND TS = (aged OR elderly OR ageing OR aging OR old)) were screened for articles published since 2010 (last search on 15 July 2011), resulting in 285 and 140 hits, respectively. Studies were included if they were written in English and if they reported interactions between CLIP and sarcopenia. Studies were excluded when dealing with specific chronic diseases (e.g. rheumatoid arthritis and diabetes), acutely ill patients (e.g. sepsis) or dementia. This procedure resulted in 18 relevant articles. Finally, the reference lists of the included studies were screened, resulting in three additional studies.

Back to Top | Article Outline
Quality assessment

Randomized controlled trials (RCTs) were assessed using the NICE checklist [9]. All assessments were performed independently by two reviewers (I.B. and I.B.); if assessment outcomes were conflicting, a consensus-based final score was attributed.

Back to Top | Article Outline
Data extraction

The main participants’ characteristics (sex, community-dwelling or institutionalized, country, population type, age) were identified. Data regarding parameters reflecting CLIP, muscle performance and muscle mass, and their interaction were identified and appraised.

Back to Top | Article Outline


Twenty-one articles were included, among which 12 with observational and nine with interventional design (four RCT and five non-RCT).

Back to Top | Article Outline
Systemic inflammatory markers

Twelve cross-sectional observational studies were identified, among which seven report on circulating interleukin (IL)-6, and/or C-reactive protein (CRP) and/or tumour necrosis factor (TNF)-α, and one study on soluble TNF-α and IL-6 receptors (Table 1). These inflammatory markers consistently showed negative associations with muscle mass [10▪▪,12▪], strength [11▪,16▪], performance [11▪,14▪▪] and aerobic fitness [18▪], as well as physical function [11▪,12▪,16▪] and frailty [13▪]. One recent longitudinal study was identified [10▪▪] linking CLIP to sarcopenia in community-dwelling elderly followed up for 5 years. These results further strengthen former observations linking sarcopenia to CLIP in cross-sectional and longitudinal studies.

Table 1-a Recent evi...
Table 1-a Recent evi...
Image Tools

It must be mentioned, however, that two studies [14▪▪,19▪▪] have included persons with knee osteoarthritis, but who were otherwise healthy, a condition that has been associated with increased inflammation [22] and might not be simply a model of physical inactivity as suggested in these publications. Furthermore, the outcome parameters reflecting sarcopenia throughout the selected studies have different applicability in the clinical context. Muscle mass is only one of the parameters and functional evaluations are currently considered as a necessary component for the diagnosis and evaluation of sarcopenia. Muscle strength and endurance can be easily evaluated (even in bedside conditions). Our group has elaborated and validated a fatigue resistance test based on grip strength as well as a simple equation to calculate grip work that can easily be integrated in comprehensive geriatric assessment [11▪]. These measures can be used in older persons even when gait speed, a measure put forward in recent consensus studies [2,23], cannot be obtained [24].

Table 1-b Recent evi...
Table 1-b Recent evi...
Image Tools
Table 1-c Recent evi...
Table 1-c Recent evi...
Image Tools
Back to Top | Article Outline
Inflammatory markers at the tissue level

Four biopsy studies (Table 1) explored intramuscular inflammation-related pathways [15▪,17▪▪,18▪,19▪▪]. In one biopsy study, IL-6 and TNF-α correlated negatively with Akt and its substrate AS160, downstream molecules of the insulin-signalling pathway that regulates GLUT-4 translocation and glucose metabolism. Inversely, the activated, phosphorylated form of AS160 (P-AS160) correlated positively with aerobic fitness [18▪]. However, these results do not allow the identification of the full pathway by which Akt and its substrates interfere with CLIP-induced sarcopenia (for review see [25]).

In one study, mitochondrial oxidative capacity, lean mass and muscle strength were decreased, whereas intramuscular CRP was increased in older inactive patients compared to the recreationally active young and old controls [19▪▪]. In another study [17▪▪], older sedentary patients showed a lower lean mass compared to young sedentary patients, and lower muscle strength than older active and young sedentary patients. Interestingly, higher intramuscular phosphorylated inhibitor of NFκB (pIKBα) and nuclear p65 subunit of NFκB were observed in older compared to young sedentary patients [17▪▪]. In this context, Thalacker-Mercer et al.[15▪] reported differentially modulated intramuscular gene expression following unaccustomed high-intensity resistance loading in old and young patients, comprising an upregulation of NFκB, as well as signal transducer and activator of transcription-3 (STAT3) and heat shock protein 70 (Hsp70) in older compared to young patients. It has previously been shown that TNF-α upregulates NFκB and muscle ring finger-1 (an ubiquitin ligase, MURF-1), resulting in increased ubiquitination of muscle proteins with subsequent dissociation of actin and myosin myofilaments and their degradation by the ubiquitin–proteasome pathway. Oxidative stress and increased NFκB signalling thus constitute important pathways linking CLIP to sarcopenia (for review see [26]).

STAT3 has previously been shown to induce expression of Hsp70 (for review see [27]). Hsp70 is one of the most stress-inducible Hsp. It acts as a chaperone to preserve muscle proteins or target them for degradation [28] and has been associated with sarcopenia [29]. A better muscle protection has been demonstrated in mice overexpressing Hsp70 [30]. Although levels of Hsp70 in peripheral blood mononuclear cells in older patients are correlated with circulating IL-6 and TNF-α, the production of Hsp in response to stress is blunted with age [31]. Therefore, the upregulated expression of Hsp70 in muscle cells reported by Thalacker-Mercer et al.[15▪] and others [32] most probably reflects the increased inflammatory milieu in the older patients, whereas the cytoprotective response remains disproportionately low.

Subcutaneous fat biopsies were analysed in two studies [20,21]: obese black and white postmenopausal women showed a higher expression of TNF-α and IL-6, which was related to lower grip strength. IL-6 was also positively related to total body fat mass [20]. In, otherwise healthy, overweight or obese elective vertebral surgery patients, subcutaneous fat IL-6 expression correlated positively with the amount of intermuscular adipose tissue (IMAT), reflecting decreased muscle quality [21]. The exact origin of IMAT in vertebral muscles of chronic back pain patients remains unclear, and might be disease-related, rather than only age-related, and less representative for sarcopenia. Nevertheless, IMAT increases with age, possibly resulting from satellite cell differentiation into adipocytes, and is a known source of proinflammatory cytokines [32]. Notably, most studies retrieved for the present review included a high proportion of overweight and obese individuals.

Back to Top | Article Outline
Long-term effects of exercise

Four relatively small-scale RCTs were identified and their quality appraised (Tables 2 and 3). Three RCTs compared different exercise interventions [33▪▪,34▪,35▪]. Circulating IL-6 (but not CRP) decreased after 12 weeks of moderate resistance training in healthy middle-aged men compared to sedentary controls. This effect, however, was related to higher baseline levels and was lost after 2 weeks of detraining [35▪]. In another study, low-intensity resistance training was compared to high-intensity resistance training in community-dwelling elderly. High-intensity resistance training showed better improvement of muscle performance and muscle mass; circulating IL-6 was not significantly influenced and TNF-α decreased only in the low-intensity resistance training group [34▪]. In nursing home residents, both aerobic and resistance training increased muscle performance compared to controls after 16 weeks. CRP, however, was reduced only after 16 weeks of detraining [33▪▪]. Notably, although not dealing with specific diseases, the participants of this study presented significant comorbidity.

Table 2-a Recent evi...
Table 2-a Recent evi...
Image Tools
Table 3
Table 3
Image Tools

Five non-RCT trials, including almost exclusively women (Table 2), reported effects of exercise on CLIP [37▪,38▪,39▪▪,40▪,41▪]. Four studies globally demonstrate significant decreases in circulating inflammatory cytokines and Hsp70, increases in muscle strength and mass, and inverse correlations between changes in inflammatory and muscular parameters. Only one study, including 14 healthy women with a mean age of only 40 years, reported no decrease in basal levels of any of the inflammatory cytokines after the intervention [38▪]. In these patients, basal and exercise-induced levels of five out of the six cytokines analysed were below the detection limit. Regarding circulating levels of IL-6, the studies from Ferreira et al.[38▪] and Ogawa et al.[40▪], not dealing with obese patients, are the only interventional studies not reporting significant changes following physical exercise. Similarly, in the previously published Quebec Family Study [42], cardiorespiratory fitness was no longer associated with CLIP when corrected for visceral adipose tissue, whereas fat mass and visceral adipose tissue remained correlated with CRP and IL-6. These results suggest adipose tissue as being a major source of CLIP, what might explain why sarcopenic obesity is associated with worse function than sarcopenia in lean individuals [2]. On the other hand, no associations between changes in IL-6 and changes in fat mass have been reported in the studies under review here.

Table 2-b Recent evi...
Table 2-b Recent evi...
Image Tools

Although reporting significant within and between group differences, in none of the RCTs’ relationships between changes in inflammatory markers and muscle performance were reported. Only Ogawa et al.[40▪] described a correlation between the relative change in CRP (significant decrease) and TNF-α (nonsignificant decrease) and the relative change in subscapular muscle thickness, suggesting (but not demonstrating) a causal relationship.

A recent review [43] concluded that increasing aerobic physical activity could be effective, especially in individuals with pronounced CLIP, and suggested further studies to determine the amount of exercise required to reduce inflammation. In this regard, the study by Onambélé-Pearson et al.[34▪] proposes that low-intensity resistance training leads to lower increases in muscle strength, but may be more efficient to reduce inflammation. Sample size, however, was small and study quality moderate. Intriguingly, although not significant, circulating IL-6 increased by 19.2% in the high-intensity resistance training group. In this context, acute exercise-induced elevations of IL-6 are a well known phenomenon, which is positively related to the intensity and duration of the exercise (see later section in this review). It remains, however, unclear whether this might have interfered with the results reported by this group. The observational studies by Buford et al.[17▪▪] and Safdar et al. [19▪▪] suggest that regular recreational physical activity may be sufficient to maintain oxidative capacity and avoid upregulation of catabolic pathways implicating NFκB at old age. An interesting exercise modality leading to decreases in inflammatory markers is hybrid training, using electrically stimulated and voluntary contractions, in that it reduces the required individual effort and the time requested for each session by roughly 50% as described by Kawaguchi et al.[39▪▪]. In addition, the hybrid training device is portable and can be placed at the bedside making its use promising in older patients with functional limitations or acute disease-induced immobility.

Back to Top | Article Outline
Acute exercise-induced effects

The use of an acute bout of exercise to induce an increase in circulating inflammatory cytokines in Beavers et al.[36▪] points to an interesting paradigm: an acute inflammatory response has beneficial effects, contributing to protection and repair, whereas chronic, long-standing inflammation is detrimental [44]. In addition, the acute inflammatory response to unaccustomed exercise-induced muscle damage does not preclude a beneficial effect of repeated long-term exercise on the basal inflammatory profile. Therefore, outcomes may vary with respect to the time point after the last exercise session at which inflammation is measured and the intensity of exercise used.

Furthermore, one study showed comparable postexercise increases in IL-6 in old and young patients [15▪]. In the light of known benefits of short-term inflammation in tissue repair, decreases in exercise-induced serum levels and in LPS-induced monocytic expression of IL-6 [41▪] may not necessarily represent a beneficial effect on CLIP, but rather reflect a decreased immunity following heavy exertion [45] or a lower level of exercise-induced muscle damage in well trained muscles. However, exercise-induced IL-6 release acts in a hormone-like fashion, increasing glucose uptake and fatty acid oxidation locally and inducing hepatic glucose production and adipose tissue lipolysis [46]. Lesser increases after exercise may, therefore, also reflect muscular adaptations in energy metabolism.

Back to Top | Article Outline
Nutritional interventions

One RCT compared nutritional supplements using soy (rich in isoflavones and leucin) or milk supplements during 4 weeks and could not identify a beneficial effect on eccentric exercise-induced systemic inflammation [36▪]. It is supposed that a high-quality protein diet, consisting of repeated small amounts of total protein (<30 g/intake) rich in essential amino acids, as well as vitamin D supplementation, alone or in association with resistance training, may have beneficial effects on CLIP and sarcopenia (for review see [47]).

Back to Top | Article Outline
Pharmaceutical interventions

No recent studies have been identified with respect to drug treatment of CLIP and sarcopenia. Potential pharmaceutical interventions include IL-6 and CRP lowering statins, angiotensin-converting enzyme inhibitors (reducing proteolytic effects of angiotensin II that inhibits phosphorylation of Forkhead box O3 (transcription factor, FOXO-3) and stimulates caspase-3), TNF-α inhibitors, nitric oxide donors (acting as calpain inhibitor), and PPAR-α agonists (downregulating NFκB) (for review see [2,48–50]). However, unless the drug can specifically be targeted to muscle tissue, major side-effects are to be expected. Targeting muscle-specific transcription factors such as MyoD, myogenin, MRF4 and myf-5 that decrease during the ageing process and are negatively influenced by TNF-α [51] might be promising. NSAIDs that may be useful in muscle weakness associated with acute inflammatory conditions [52] (I. Beyer et al., unpublished observation) have not yet shown clear benefits on CLIP [48].

Back to Top | Article Outline


Recent research strengthens CLIP's relationship with sarcopenia, with TNF-α and IL-6 as most reported inflammatory parameters. Adiposity contributes to CLIP and new studies should take fat mass into account. Underlying mechanisms are progressively unravelled, including oxidative and proteolytic pathways. Physical exercise seems the best intervention to reduce CLIP and counter sarcopenia. However, IL-6 is also released during exercise as an energy-signalling molecule, in a hormone-like fashion unrelated to inflammation, and exercise-induced changes in IL-6 require careful interpretation. To date, an optimal amount of exercise remains elusive, and more research is warranted to unravel the exact dose–response relationship.

Back to Top | Article Outline



Back to Top | Article Outline
Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline


Papers of particular interest, published within the annual period of review, have been highlighted as:

▪ of special interest

▪▪ of outstanding interest

Additional references related to this topic can also be found in the Current World Literature section in this issue (p. 93).

Back to Top | Article Outline


1. Rosenberg IH. Summary comments. Am J Clin Nutr 1989; 50:1231–1233.

2. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12:249–256.

3. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687–699.

4. Thomas DR. Sarcopenia. Clin Geriatr Med 2010; 26:331–346.

5. Zanni F, Vescovini R, Biasini C, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 2003; 38:981–987.

6. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98:1154–1162.

7. Stewart LK, Flynn MG, Campbell WW, et al. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun 2005; 19:389–397.

8. Franceschi C, Capri M, Monti D, et al. Inflammaging and antiinflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128:92–105.

9. NICE. Methodology checklist: randomised controlled trials. 2009. [Accessed August 2011]

Aleman H, Esparza J, Ramirez FA, et al. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing 2011; 40:469–475.

Longitudinal studies are paramount as longitudinal evidence is scant.

Bautmans I, Onyema O, Van Puyvelde K, et al. Grip work estimation during sustained maximal contraction: validity and relationship with physical dependency and inflammation in elderly persons. J Nutr Health Aging 2011; 15:731–736.

In this study, inflammation is related to muscle parameters that are easy to use in multiple settings.

Haren MT, Malmstrom TK, Miller DK, et al. Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol 2010; 65:274–281.

Relatively large cohort study that uses sTNFR levels that are more stable than TNF-α itself and may better reflect the level of inflammation.

Leng SX, Tian X, Matteini A, et al. IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 2011; 40:475–481.

This study relates monocyte/macrophage activity to the clinical syndrome of frailty based on the Fried phenotype that includes weakness, fatigue and physical performance.

Santos ML, Gomes WF, Pereira DS, et al. Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA). Arch Gerontol Geriatr 2011; 52:322–326.

Apart from strength, two other important parameters of muscle function, endurance and flexor/extensor balance, are evaluated and are correlated with the degree of inflammation.

Thalacker-Mercer AE, Dell’Italia LJ, Cui X, et al. Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading. Physiol Genomics 2010; 40:141–149.

Transcriptome analysis is a promising technique having numerous applications and may help to unravel complex underlying pathways.

Tiainen K, Hurme M, Hervonen A, et al. Inflammatory markers and physical performance among nonagenarians. J Gerontol 2010; 65:658–663.

The relationship between inflammation and muscle weakness, as well as functional measures, is demonstrated in the oldest old, whether community dwelling or institutionalized.

Buford TW, Cooke MB, Manini TM, et al. Effects of age and sedentary lifestyle on skeletal muscle NF-kappaB signaling in men. J Gerontol 2010; 65:532–537.

NFκB plays a central role in inflammation and muscle protein catabolism and is related here to age and physical inactivity.

Levinger I, Howlett KF, Peake J, et al. Akt, AS160, metabolic risk factors and aerobic fitness in middle-aged women. Exerc Immunol Rev 2010; 16:98–104.

At the crossroads of Akt signalling: pathways related to glucose metabolism are inhibited by TNF-α in this study. Akt signalling downstream from IGF-1 is known to promote muscle protein synthesis.

Safdar A, Hamadeh MJ, Kaczor JJ, et al. Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One 2010; 5:e10778.

Sedentary lifestyle, in addition to ageing itself, is related to increased oxidative stress that plays a pivotal role in the pathogenesis of sarcopenia.

20. Wang X, You T, Yang R, et al. Muscle strength is associated with adipose tissue gene expression of inflammatory adipokines in postmenopausal women. Age Ageing 2010; 39:656–659.

21. Zoico E, Rossi A, Di Francesco V, et al. Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol 2010; 65:295–299.

22. Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7:33–42.

23. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis – report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412–423.

24. Brass EP, Sietsema KE. Considerations in the development of drugs to treat sarcopenia. J Am Geriatr Soc 2011; 59:530–535.

25. Saini A, Faulkner S, Al-Shanti N, Stewart C. Powerful signals for weak muscles. Ageing Res Rev 2009; 8:251–267.

26. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007; 102:2389–2397.

27. Stephanou A, Latchman DS. Transcriptional modulation of heat-shock protein gene expression. Biochem Res Int 2011; 2011:238601.

28. Calderwood SK, Murshid A, Prince T. The shock of aging: molecular chaperones and the heat shock response in longevity and aging: a mini-review. Gerontology 2009; 55:550–558.

29. Lee CE, McArdle A, Griffiths RD. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clin Nutr 2007; 26:524–534.

30. McArdle A, Dillmann WH, Mestril R, et al. Overexpression of Hsp70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. FASEB J 2004; 18:355–357.

31. Njemini R, Abeele MV, Demanet C, et al. Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol 2002; 22:195–205.

32. Peake J, Della Gatta P, Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol 2010; 298:R1485–R1495.

Martins RA, Neves AP, Coelho-Silva MJ, et al. The effect of aerobic versus strength-based training on high-sensitivity C-reactive protein in older adults. Eur J Appl Physiol 2010; 110:161–169.

Aerobic and resistance training is beneficial in institutionalized individuals in terms of inflammation and strength and should encourage structured, individually tailored exercise programmes in this specific setting.

Onambélé-Pearson G, Breen L, Stewart C. Influence of exercise intensity in older persons with unchanged habitual nutritional intake: skeletal muscle and endocrine adaptations. Age 2010; 32:139–153.

This study explores different exercise regimens in order improve compliance. Evaluations of exercise programmes able to address specific individuals and outcomes merit further attention.

Thompson D, Markovitch D, Betts JA, et al. Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. J Appl Physiol 2010; 108:769–779.

Home-based exercise appears to be a promising tool for prevention, especially at higher levels of CLIP.

Beavers KM, Serra MC, Beavers DP, et al. Soy and the exercise-induced inflammatory response in postmenopausal women. Appl Physiol Nutr Metab 2010; 35:261–269.

This study addresses isoflavone supplementation. Nutritional interventions, alone or in combination with exercise, certainly require further attention as large-scale preventive and/or therapeutic tools.

Córdova C, Lopes ESF Jr, Pires AS, et al. Long-term resistance training is associated with reduced circulating levels of IL-6, IFN-gamma and TNF-alpha in elderly women. Neuroimmunomodulation 2011; 18:165–170.

Resistance training appears to result in quite important decreases in inflammatory markers when of sufficient intensity and duration.

Ferreira FC, de Medeiros AI, Nicioli C, et al. Circuit resistance training in sedentary women: body composition and serum cytokine levels. Appl Physiol Nutr Metab 2010; 35:163–171.

Effects of favourable changes in body composition, without weight change, on CLIP merit further investigations in larger cohorts.

Kawaguchi T, Shiba N, Takano Y, et al. Hybrid training of voluntary and electrical muscle contractions decreased fasting blood glucose and serum interleukin-6 levels in elderly people: a pilot study. Appl Physiol Nutr Metab 2011; 36:276–283.

A new training method that may improve adherence to exercise programmes and outcomes.

Ogawa K, Sanada K, Machida S, et al. Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediat Inflamm 2010; 2010:171023.

Interventional study in the oldest old institutionalized subjects, demonstrating favourable effects on muscle mass and on inflammatory markers – translation into physical function merits further attention.

Phillips MD, Flynn MG, McFarlin BK, et al. Resistance training at eight-repetition maximum reduces the inflammatory milieu in elderly women. Med Sci Sports Exerc 2010; 42:314–325.

The effects of exercise on basal and stimulated levels of inflammatory markers, and the relationship between them, are an intriguing area of research.

42. Arsenault BJ, Cartier A, Cote M, et al. Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Am J Cardiol 2009; 104:240–246.

43. Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta 2010; 411:785–793.

44. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010; 140:771–776.

45. Archer T, Fredriksson A, Schutz E, Kostrzewa RM. Influence of physical exercise on neuroimmunological functioning and health: aging and stress. Neurotox Res 2011; 20:69–83.

46. Pedersen BK. Muscles and their myokines. J Exp Biol 2011; 214 (Pt 2):337–346.

47. Waters DL, Baumgartner RN, Garry PJ, Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010; 5:259–270.

48. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev 2011; 10:319–329.

49. Koh TJ, Tidball JG. Nitric oxide inhibits calpain-mediated proteolysis of talin in skeletal muscle cells. Am J Physiol 2000; 279:C806–C812.

50. Yessoufou A, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly 2010; 140:w13071.

51. Degens H. The role of systemic inflammation in age-related muscle weakness and wasting. Scand J Med Sci Sports 2010; 20:28–38.

52. Mets T, Bautmans I, Njemini R, et al. The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. Am J Geriatr Pharmacother 2004; 2:230–238.

Cited By:

This article has been cited 5 time(s).

Journal of the American Geriatrics Society
Tongue Strength Is Associated with Jumping Mechanography Performance and Handgrip Strength but Not with Classic Functional Tests in Older Adults
Buehring, B; Hind, J; Fidler, E; Krueger, D; Binkley, N; Robbins, J
Journal of the American Geriatrics Society, 61(3): 418-422.
Current Pharmaceutical Design
Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised
Salvioli, S; Monti, D; Lanzarini, C; Conte, M; Pirazzini, C; Bacalini, MG; Garagnani, P; Giuliani, C; Fontanesi, E; Ostan, R; Bucci, L; Sevini, F; Yani, SL; Barbieri, A; Lomartire, L; Borelli, V; Vianello, D; Bellavista, E; Martucci, M; Cevenini, E; Pini, E; Scurti, M; Biondi, F; Santoro, A; Capri, M; Franceschi, C
Current Pharmaceutical Design, 19(9): 1675-1679.

Clinical Lipidology
Marine n-3 polyunsaturated fatty acids: a potential role in the treatment of sarcopenia
Gray, S; Da Boit, M
Clinical Lipidology, 8(2): 187-194.
Calcified Tissue International
Quality of Life in Sarcopenia and Frailty
Rizzoli, R; Reginster, JY; Arnal, JF; Bautmans, I; Beaudart, C; Bischoff-Ferrari, H; Biver, E; Boonen, S; Brandi, ML; Chines, A; Cooper, C; Epstein, S; Fielding, RA; Goodpaster, B; Kanis, JA; Kaufman, JM; Laslop, A; Malafarina, V; Manas, LR; Mitlak, BH; Oreffo, RO; Petermans, J; Reid, K; Rolland, Y; Sayer, AA; Tsouderos, Y; Visser, M; Bruyere, O
Calcified Tissue International, 93(2): 101-120.
Journal of the American Medical Directors Association
Nonsteroidal Anti-Inflammatory Drug (NSAID) Use and Sarcopenia in Older People: Results From the ilSIRENTE Study
Landi, F; Marzetti, E; Liperoti, R; Pahor, M; Russo, A; Martone, AM; Colloca, G; Capoluongo, E; Bernabei, R
Journal of the American Medical Directors Association, 14(8): -.
Back to Top | Article Outline

exercise; low-grade inflammation; sarcopenia

© 2012 Lippincott Williams & Wilkins, Inc.


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.